These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32296024)

  • 21. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of DAPK Gene Methylation Patterns in the Diagnosis of Leukemia].
    Ye SS; Liu XJ; Mao BY; Yang L; Qiu G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):687-92. PubMed ID: 27342491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications.
    Wong IH; Ng MH; Huang DP; Lee JC
    Blood; 2000 Mar; 95(6):1942-9. PubMed ID: 10706859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA Methylation Markers for Pan-Cancer Prediction by Deep Learning.
    Liu B; Liu Y; Pan X; Li M; Yang S; Li SC
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31590287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients.
    Gao H; He X; Li Q; Wang Y; Tian Y; Chen X; Wang J; Guo Y; Wang W; Li X
    Cancer Med; 2020 Sep; 9(17):6296-6305. PubMed ID: 32628355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting amplification of
    Giwa A; Rossouw SC; Fatai A; Gamieldien J; Christoffels A; Bendou H
    Future Oncol; 2021 Dec; 17(34):4769-4783. PubMed ID: 34751044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between DNA methylation of the ABO gene promoter CpG island and leukemia].
    Xu H; Bao GQ; Wang BY; Xing HX; Ye SH; Zhang JG; Yu CY; Tan YX; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):240-6. PubMed ID: 18426641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
    Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
    Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia.
    Qian J; Chen Q; Yao DM; Yang L; Yang J; Wen XM; Zhang YY; Chai HY; Ma JC; Deng ZQ; Lin J
    Int J Clin Exp Pathol; 2015; 8(1):127-36. PubMed ID: 25755699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen.
    Schmutz M; Zucknick M; Schlenk RF; Mertens D; Benner A; Weichenhan D; Mücke O; Döhner K; Plass C; Bullinger L; Claus R
    Clin Epigenetics; 2023 Oct; 15(1):171. PubMed ID: 37885041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
    Li T; Chen X; Gu M; Deng A; Qian C
    Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.